SEARCH

HOME / SEARCH / Vemurafenib and panitumumab (in BRAF V600E mutated)

iGMDRD597

Canonical SMILES: CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F

InChI: InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)

InChI Key: GPXBXXGIAQBQNI-UHFFFAOYSA-N

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Vemurafenib and panitumumab (in BRAF V600E mutated)	CHEMBL1229517	42611300	DB08881	Combination	Small Molecule

Drug Class:

Amides Antineoplastic Agents Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Substrates Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Heterocyclic Compounds Heterocyclic Compounds, 2-Ring Highest Risk QTc-Prolonging Agents Kinase Inhibitor Protein Kinase Inhibitors QTc Prolonging Agents Sulfones Sulfur Compounds

Drug Targets:

BRAF (P15056)

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Gene ID	Gene Name	Model Num.
8731	RNMT	1

Gene in drug-gene network: Network Plot

Models in Vemurafenib and panitumumab (in BRAF V600E mutated)

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.